Joan E Davies
Overview
Explore the profile of Joan E Davies including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
935
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study
Kanagala P, Squire I, Jones D, Cao T, Chan D, McCann G, et al.
Clin Res Cardiol
. 2019 Feb;
108(8):940-949.
PMID: 30767059
Background: Proenkephalin (PENK), a stable endogenous opioid biomarker related to renal function, has prognostic utility in acute and chronic heart failure. We investigated the prognostic utility of PENK in heart...
2.
Ng L, Squire I, Jones D, Cao T, Chan D, Sandhu J, et al.
J Am Coll Cardiol
. 2017 Jan;
69(1):56-69.
PMID: 28057251
Background: Proenkephalin A (PENK) and its receptors are widely distributed. Enkephalins are cardiodepressive and difficult to measure directly. PENK is a stable surrogate analyte of labile enkephalins that is correlated...
3.
Ng L, Bhandari S, Sandhu J, Quinn P, Squire I, Davies J, et al.
Biomarkers
. 2015 Nov;
20(6-7):371-5.
PMID: 26525661
Context: Excess growth hormone (GH) is associated with early mortality. Objectives: We assessed the association of GH with prognosis after acute myocardial infarction (AMI), and the effects of secondary prevention...
4.
Ng L, Sandhu J, Narayan H, Quinn P, Squire I, Davies J, et al.
J Am Coll Cardiol
. 2014 Oct;
64(16):1698-707.
PMID: 25323258
Background: Pro-substance P (ProSP) is a stable surrogate marker for labile substance P, which has pro-inflammatory effects, increases platelet aggregation and clot strength, and reduces fibrinolysis. Objectives: This study assessed...
5.
Ng L, Sandhu J, Narayan H, Quinn P, Squire I, Davies J, et al.
J Am Coll Cardiol
. 2013 Oct;
63(3):280-9.
PMID: 24140658
Objectives: The goal of this research was to assess the prognostic value of proenkephalin (PENK) levels in acute myocardial infarction (AMI) by using N-terminal pro-B-type natriuretic peptide and Global Registry...
6.
Ng L, Sandhu J, Squire I, Davies J, Jones D
Int J Cardiol
. 2013 Feb;
168(3):2341-6.
PMID: 23415169
Background: Vitamin D status (VDS) has been linked to mortality and incident acute myocardial infarction (AMI) in healthy cohorts. Associations with recurrent adverse cardiovascular events in those with cardiovascular disease...
7.
Khoo J, Davies J, Ang K, Galinanes M, Chin D
Heart
. 2012 Aug;
99(1):41-7.
PMID: 22895641
Background: In patients being considered for aortic valve replacement, there remains controversy over which design or tissue offers the best performance. We aimed to evaluate in a single study the...
8.
Dhillon O, Narayan H, Khan S, Kelly D, Quinn P, Squire I, et al.
Int J Cardiol
. 2012 Jul;
167(5):2182-8.
PMID: 22835988
Background: Soluble ST2 is a marker of cellular stress and injury whose natural ligand is interleukin-33. We investigate, for the first time, the relationship of IL-33 and ST2 with death...
9.
Dhillon O, Narayan H, Quinn P, Squire I, Davies J, Ng L
Am Heart J
. 2011 Jun;
161(6):1163-70.
PMID: 21641364
Background: Soluble ST2 is a marker of biomechanical strain for which the natural ligand is interleukin 33 (IL-33). They have not been studied together in non-ST-elevation myocardial infarction (NSTEMI). We...
10.
Narayan H, Dhillon O, Quinn P, Struck J, Squire I, Davies J, et al.
Clin Sci (Lond)
. 2011 Feb;
121(2):79-89.
PMID: 21309746
Copeptin, the 39-amino-acid C-terminal portion of provasopressin, has been shown to be an independent predictor for adverse events following STEMI (ST elevation myocardial infarction). We hypothesized that plasma copeptin was...